In models of melanoma, lung and breast cancers, a subset of “persister” cells that survive treatment displayed chronic, ...

Artificial intelligence (AI) can predict how well patients with rectal cancer will respond to treatment by analyzing standard tissue samples taken during diagnosis, finds a new study from researchers ...

Stage 2 vaginal cancer involves spread beyond the vaginal wall but not to the pelvic sidewall, with symptoms like abnormal ...

Immunotherapy—could that be an option for me, doctor?” is a question frequently asked by patients with colorectal cancer. The ...

A Singaporean research team has developed CAN-Scan (short for Cancer Scan), a next-generation precision oncology platform ...

The combination of alnodesertib and irinotecan shows promising efficacy in ATM-negative metastatic colorectal cancer, with a ...

WRN inhibitors are attracting increasing attention as a niche but fast-emerging segment within precision oncology, driven by their role in targeting DNA repair vulnerabilities. Promising candidates, ...

Mass General Brigham study tracks how the tumor microenvironment develops during progression, signaling an opportunity for early detection and risk prediction ...

The U.S. Food and Drug Administration has granted Fast Track Designation to a new drug combination for metastatic colorectal ...

CytomX Therapeutics, Inc.'s ADC candidate, CX-2051, shows promise in colorectal cancer. Click here to read an analysis of ...

The U.S. Food and Drug Administration has granted Fast Track Designation to a new drug combination for metastatic colorectal cancer, following encouraging results from a clinical trial led in part by ...